11
Views
21
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Nitric Oxide in Hypertension and Renal Diseases

&
Pages 353-357 | Published online: 08 Jul 2009

References

  • Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–12
  • Änggård E. Nitric oxide: mediator, murderer, and medicine. Lancer 1994; 343: 1199–206
  • Clapp W L, Wilcox C S, Kone B C. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 1994; 46: 653–65
  • Lüscher T F, Bock H A, Yang Z, Diederich D. Endothelium-derived relaxing and contracting factors: perspectives in nephrology. Kidney Int 1991; 39: 575–90
  • Raij L. Nitric oxide and the kidney. Circulation 1993; 87(Suppl V)V26–9
  • Vercellotti G M, Tolins J R. Endothelial activation and the kidney: vasomotor modulation and antioxidant strategies. Am J Kidney Dis 1993; 21: 331–3
  • Rees D D, Palmer R MJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375–8
  • Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxid synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278–81
  • Salazar F J, Pinilla J M, López F, Romero J C, Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 1992; 20: 113–7
  • Morton J J, Beattie E C, Speirs A, Gulliver F. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. Hypertension 1993; 11: 1083–8
  • Pollock D M, Polakowski J S, Divish B J, Opgenorth T J. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 1993; 21: 660–6
  • Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man. Lancet 1989; ii: 997–1000
  • Shirasaki Y, Kolm R, Nickols G A, Lee T J-F. Endothelial regulation of cyclic GMP and vascular responses in hypertension. J Pharmacol Exp Ther 1988; 245: 53–8
  • Nakamura T, Prewitt R L. Effect of NG-monomethyl L-arginine on endothelium-dependent relaxation in arterioles of one-kidney, one clip hypertensive rats. Hypertension 1991; 17: 875–80
  • Panza J A, Casino P R, Kilcoyne C M, Quyyumi A A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Circulation 1993; 87: 1468–74
  • Taddei S, Virdis A, Mattel P, Salvetti A. Vasodilatation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929–33
  • Cockcroft J R, Chowienczyk P J, Benjamin N, Ritter J M. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036–40
  • Taddei S, Virdis A, Mattel P, Arzilli F, Salvetti A. Endothelium-dependent forearm vasodilation is reduced in normotensive subjects with family history of hypertension. J Cardiovasc Pharmacol 1992; 20(Suppl 12)S193–5
  • Busse R, Fleming I. The endothelial organ. Curr Opin Cardiol 1993; 8: 719–27
  • Cachoferiro V, Sakakibara T, Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension 1992; 19: 138–45
  • Kähönen M, Mäkynen H, Arvola P, Pörsti I. Enhancement of arterial relaxation by long-term atenolol treatment in spontaneously hypertensive rats. Br J Pharmacol 1994; 112: 925–33
  • Lyons D, Webster J, Benjamin N. The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension. Hypertension 1994; 12: 1047–52
  • Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 1990; 16: 532–40
  • Schultz P J, Tolins J P. Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin invest 1993; 91: 642–50
  • Manning R D, Jr, Hu L. Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs. Hypertension 1994; 23: 619–25
  • Ikenaga H, Suzuki H, Ishii N, Itoh H, Saruta T. Role of NO in pressure-natriuresis in Wistar-Kyoto and spontaneously hypertensive rats. Kidney Int 1993; 43: 205–11
  • Majid D SA, Williams A, Kadowitz P J, Navar L G. Renal responses to intra-arterial administration of nitric oxide in dogs. Hypertension 1993; 22: 535–41
  • Patel A, Layne S, Watts D, Kirchner K A. L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats. Hypertension 1993; 22: 863–9
  • Saijonmaa O, Ristimäki A, Fyhrquist F. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun 1990; 173: 514–20
  • Kumagai K, Suzuki H, Ichikawa M, et al. Nitric oxide increases renal blood flow by interacting with the sympathetic nervous system. Hypertension 1994; 24: 220–6
  • Cartel V, Largen P, De Heer E, Cook T. Glomeruli synthesize nitrite in active Heymann nephritis. The source is infiltrating macrophages. Kidney Int 1991; 40: 847–51
  • Cook H T, Sullivan R. Glomerular nitrite synthesis in situ immune complex glomerulonephritis in the rat. Am J Pathol 1991; 139: 1047–52
  • Jansen A, Cook T, Taylor M, et al. Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 1994; 45: 1215–9
  • Ketteler M, Narita I, Border W A, Noble N A. Nitric oxide-inhibition prevents mesangial cell lysis in experimental glomerulonephritis. J Am Soc Nephrol 1993; 4: 610
  • Weinberg J B, Granger D L, Pisetsky D S, et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous nephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994; 179: 651–60
  • Bank N, Aynedjian H S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993; 43: 1306–12
  • Tolins J P, Raij L. Effects of aminoacid infusion on renal hemodynamics. Role of endothelium-derived relaxing factor. Hypertension 1991; 17: 1045–51
  • Shultz P J, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718–25
  • Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94: 1069–75
  • Tikkanen I, Uhlenius N, Tikkanen T, et al. Renoprotective role of nitric oxide (NO) in Heymann nephritis (HN). J Am Soc Nephrol 1994; 5: 594
  • Munger K A, Fogo A, Nassar G, Badr K F. A protective role of nitric oxide (NO) in the acute neutrophil (PMN)-dependent phase of nephrotoxic (NTS) nephritis in rats. J Am Soc Nephrol 1994; 5: 588
  • Chen P Y, Sanders P W. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993; 22: 812–8
  • Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572–5
  • Craven P A, Studer R K, DeRubertis F R. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic responses. J Clin Invest 1994; 93: 311–20
  • McLay J S, Chatterjee P, Nicolson A G, et al. Nitric oxide production by human proximal tubular cells: A novel immunomodulatory mechanism?. Kidney Int 1994; 46: 1043–9
  • Lüscher T F, Haefell W E. L-arginine in the clinical arena: tool or remedy?. Circulation 1993; 87: 1746–8
  • Reyes A A, Purkerson M L, Karl L, Klahr S. Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992; 20: 168–76
  • Reyes A A, Porras B H, Chasalow F I, Klahr S. L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 1994; 45: 1346–54

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.